市場調查報告書
商品編碼
1320987
尿路感染檢測市場-按測試類型(尿液分析、尿培養、藥敏測試)、按測試套件類型(實驗室測試套件、家庭測試套件)、按應用(尿道炎、膀胱炎、腎盂腎炎)、按最終用途和預測, 2023-2032Urinary Tract Infection Testing Market-By Test Type (Urinalysis, Urine Cultures, Susceptibility Testing), By Test Kit Type (Laboratory Test Kits, Home Test Kits), By Application (Urethritis, Cystitis, Pyelonephritis), By End-use & Forecast, 2023-2032 |
到 2032 年,全球尿路感染檢測市場規模將大幅擴大。有利的報銷政策、促進醫療基礎設施發展的政府舉措以及不斷成長的老年人口推動了尿路感染檢測市場的發展。例如,美國衛生與公眾服務部 (HHS) 發起了尿路感染預防和控制 (UTI-PCC) 計劃。該計劃的重點是提高人們對尿路感染的認知,並為醫療保健提供者和患者提供資源。
由於對有效診斷解決方案的需求不斷增加以及尿路感染髮病率上升(主要是女性和老年人),市場將會擴大。人們越來越意識到未經治療的尿路感染的潛在併發症以及對早期準確檢測方法的需求推動了市場的發展。此外,從長遠來看,分子診斷和自動尿液分析儀等診斷技術的技術進步將增強市場潛力。
整個尿路感染檢測市場根據測試類型、應用、最終用戶和地區進行分類。
就測試類型而言,到 2032 年,尿液分析領域將佔據一定的市場佔有率。尿液分析是用於檢測和診斷尿路感染的常見且重要的診斷工具。它涉及對尿液樣本進行分析,以確定是否存在細菌、白細胞和其他感染指標。全球尿路感染髮病率的不斷上升將推動對尿液分析的需求,將其作為支持其增強的主要測試方法。因此,尿路感染檢測市場對尿液分析的需求仍然很高。
根據該應用,尿道炎細分市場將在 2022 年至 2023 年間呈現巨大成長。人們對未經治療的尿道炎併發症的認知不斷提高,以及性傳播感染髮病率的上升,增加了專門針對尿道炎的尿路感染檢測的需求。尿路感染檢測方法,如尿培養、分子診斷和快速抗原檢測,用於識別引起尿道炎的病原體的存在,從而導致了更多的需求。因此,採用率的不斷提高將支持尿道炎領域。
根據最終用途,診斷實驗室在預測期內將以驚人的成長率成長。這些實驗室在準確、及時診斷尿路感染方面發揮著至關重要的作用,並有助於預防尿路感染。人們越來越認知到早期尿路感染檢測的重要性,並且尿路感染病例數量不斷增加,推動了診斷實驗室對尿路感染檢測的需求。此外,醫療保健提供者依靠診斷實驗室來進行各種測試,包括尿培養、尿液分析和分子診斷。因此,UTI 測試市場受益於這些設施產生的持續需求。
從地區來看,由於亞太地區尿路感染的患病率不斷上升,亞太地區尿路感染檢測市場可能會積累可觀的市場佔有率。政府改善醫療基礎設施的舉措和不斷增加的醫療支出進一步推動了亞太地區尿路感染檢測市場的發展。此外,主要市場參與者的存在和創新診斷解決方案的採用有助於該地區的行業成長。
Global Urinary Tract Infection Testing Market size will expand significantly through 2032. Favorable reimbursement policies, government initiatives promoting healthcare infrastructure development, and the rising geriatric population boost the UTI testing market. For instance, the U.S. Department of Health and Human Services (HHS) launched the Urinary Tract Infection Prevention and Control (UTI-PCC) initiative. The initiative focuses on raising awareness of UTIs and providing resources to healthcare providers and patients.
The market will expand due to the increasing need for effective diagnostic solutions and the rising incidence of UTIs, primarily among women and aging people. The growing awareness about the potential complications of untreated UTIs and a need for early and accurate testing methods drives the market. Additionally, technological advancements in diagnostic techniques, such as molecular diagnostics and automated urine analyzers, will boost market potential in the long run.
The overall Urinary Tract Infection Testing Market is classified based on test type, application, end-user, and region.
Regarding the test type, the urinalysis segment will capture a modest market share by 2032. Urinalysis is a common and essential diagnostic tool used to detect and diagnose UTIs. It involves the analysis of urine samples to identify the presence of bacteria, white blood cells, and other indicators of infection. The increasing incidence of UTIs globally will push the demand for urinalysis as a primary testing method supporting its augmentation. Consequently, the demand for urinalysis in the UTI testing market remains high.
Based on the application, the urethritis segment will exhibit tremendous growth between 2022-2023. The increasing awareness about the complications of untreated urethritis and the rising incidence of sexually transmitted infections contribute to the demand for UTI testing specifically targeting urethritis. UTI testing methods, such as urine culture, molecular diagnostics, and rapid antigen tests, are utilized to identify the presence of pathogens causing urethritis, leading to more demand. Therefore, the increasing rate of adoption will support the urethritis segment.
Based on the end-use, diagnostic laboratories will rise with an admirable growth rate during the forecast period. These laboratories play a vital role in accurate and timely diagnosis of UTIs and can help prevent them. The increasing awareness about the importance of early UTI detection and the growing volume of UTI cases drive the demand for UTI testing in diagnostic laboratories. Additionally, Healthcare providers rely on diagnostic laboratories to perform various tests, including urine cultures, urinalysis, and molecular diagnostics. As a result, the UTI Testing Market benefits from the continuous demand generated by these facilities.
Regionally, APAC urinary tract infection testing market could accumulate a substantial market share due to the growing prevalence of UTIs in the Asia Pacific region. The government initiatives to improve healthcare infrastructure and the increasing healthcare expenditure further propel the UTI testing market in APAC. Moreover, the presence of major market players and the adoption of innovative diagnostic solutions contribute to industry growth in the region.